OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) - GEMPHIRE THERAPEUTICS INC ownership

GEMPHIRE THERAPEUTICS INC's ticker is GEMP and the CUSIP is 36870A108. A total of 29 filers reported holding GEMPHIRE THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) ownership history of GEMPHIRE THERAPEUTICS INC
ValueSharesWeighting
Q2 2018$265,000,000
-44.4%
26,000
-64.5%
0.01%
-44.4%
Q1 2018$477,000,00073,3000.01%
Other shareholders
GEMPHIRE THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
VHCP Management III, LLC 869,538$1,000,0000.58%
VHCP Management II, LLC 513,752$591,0000.17%
Exchange Capital Management, Inc. 522,481$601,0000.17%
GM Advisory Group, LLC 43,335$50,0000.02%
Truvestments Capital LLC 4,926$6,0000.01%
Cambridge Investment Research Advisors, Inc. 173,044$199,0000.00%
B. Riley Wealth Management, Inc. 10,000$12,0000.00%
ERTS Wealth Advisors, LLC 4,112$3,0000.00%
SEGALL BRYANT & HAMILL, LLC 30,000$35,0000.00%
Advisory Services Network, LLC 12,910$15,0000.00%
View complete list of GEMPHIRE THERAPEUTICS INC shareholders